Osmotica Pharmaceuticals plc | Business Contracts

Second Amendment to Note Purchase Agreement, dated March 8, 2023, by and among RevitaLid (Filed With SEC on March 20, 2023)

Amendment to License Agreement, effective as of March 31, 2022, by and between RVL Pharmaceuticals, Inc. and Santen Pharmaceutical Co. Ltd (Filed With SEC on April 4, 2022)

Amendment to Employment Agreement, dated July 29, 2021, by and between RVL Pharmaceuticals, Inc. and Brian A. Markison (Filed With SEC on March 30, 2022)

Description of Registrants Securities (Filed With SEC on March 30, 2022)

Sales Agreement, dated as of September 8, 2021, by and between Osmotica Pharmaceuticals plc and Cantor Fitzgerald & Co (Filed With SEC on September 8, 2021)

Employment Agreement, dated December 3, 2015, by and between Vertical/Trigen Holdings, LLC and Brian A. Markison (Filed With SEC on March 30, 2022)

RVL Pharmaceuticals plc Amended and Restated 2018 Incentive Plan (Filed With SEC on March 30, 2022)

Amended and Restated RVL Pharmaceuticals plc 2016 Equity Incentive Plan (Filed With SEC on March 30, 2022)

RVL Pharmaceuticals plc Amended and Restated 2018 Employee Share Purchase Plan (Filed With SEC on March 30, 2022)

Form of Nonqualified Option Award Agreement under the RVL Pharmaceuticals plc Amended and Restated 2018 Incentive Plan (Filed With SEC on March 30, 2022)

Amendment to Employment Agreement, by and between RVL and Brian Markison, dated November 5, 2021 (Filed With SEC on November 10, 2021)

Form of Warrant (Filed With SEC on October 12, 2021)

Underwriting Agreement, dated October 6, 2021, by and between Osmotica Pharmaceuticals plc and H.C. Wainwright & Co., LLC (Filed With SEC on October 12, 2021)

Share Subscription Agreement dated October 1, 2021, between Osmotica Pharmaceuticals plc and Athyrium Opportunities IV Acquisition LP (Filed With SEC on October 6, 2021)

Note Purchase Agreement dated October 1, 2021, between Osmotica Pharmaceutical Corp., Osmotica Pharmaceuticals plc, Osmotica Holdings US LLC, Athyrium Opportunities IV Acquisition... (Filed With SEC on October 6, 2021)

Contingent Amendment Agreement, dated as of June 24, 2021, by and among Osmotica Pharmaceutical Corp., Valkyrie Group Holdings, Inc., certain other subsidiaries of Osmotica... (Filed With SEC on June 30, 2021)

Purchase and Sale Agreement, dated as of June 24, 2021, by and among Osmotica Pharmaceuticals plc, Acella Holdings, LLC, Alora Pharmaceuticals, LLC and the Sellers listed therein (Filed With SEC on June 30, 2021)

Description of Osmotica Securities (Filed With SEC on March 30, 2021)

Amendment No. 1, dated as of November 20, 2020, to the Shareholders Agreement, dated as of October 17, 2018, by and among, Osmotica Pharmaceuticals plc, ACP Holdco (Offshore),... (Filed With SEC on March 30, 2021)

Osmotica-Form of Director Restricted Stock Unit Award Agreement under the Osmotica Pharmaceuticals plc 2018 Incentive Plan (Filed With SEC on August 11, 2020)

Osmotica-Form of Performance Stock Unit Award Agreement under the Osmotica Pharmaceuticals plc 2018 Incentive Plan (Filed With SEC on August 11, 2020)

Osmotica-Form of Restricted Stock Unit Award Agreement under the Osmotica Pharmaceuticals plc 2018 Incentive Plan (Filed With SEC on August 11, 2020)

Osmotica Pharmaceuticals plc Amended and Restated 2018 Employee Share Purchase Plan (Filed With SEC on August 11, 2020)

Underwriting Agreement, dated July 13, 2019, by and between Osmotica Pharmaceuticals plc and Credit Suisse Securities (USA) LLC (Filed With SEC on July 15, 2020)

Form of Additional Annual Retainer Agreement (In Lieu of Equity Awards) with Osmotica Pharmaceuticals plc Directors (Filed With SEC on March 19, 2020)

Form of Initial Retainer Agreement (In Lieu of Equity Awards) with Osmotica Pharmaceuticals plc Directors (Filed With SEC on March 19, 2020)

Employment Agreement, dated December 16, 2013, by and between Vertical/Trigen Opco, LLC and Christopher Klein (Filed With SEC on March 19, 2020)

Description of Osmotica Securities (Filed With SEC on March 19, 2020)

Form of Underwriting Agreement (Filed With SEC on January 6, 2020)

Osmotica Pharmaceuticals plc Amended and Restated 2018 Employee Share Purchase Plan (Filed With SEC on August 8, 2019)

Employment Agreement, dated September 13,2017, by and between Vertical/Trigen Opco, LLC and Andrew Einhorn (Filed With SEC on May 9, 2019)

Shareholders' Agreement (Filed With SEC on March 28, 2019)

Osmotica Pharmaceuticals plc (32)